Published in World J Cardiol on April 26, 2017
Drug-induced prolongation of the QT interval. N Engl J Med (2004) 10.96
Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol (2006) 5.39
The long Q-T syndrome. Am Heart J (1975) 3.75
QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation (1978) 3.32
QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet (1993) 2.73
Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology (2006) 2.62
QT interval: how to measure it and what is "normal". J Cardiovasc Electrophysiol (2006) 1.89
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut (2003) 1.76
Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease. Hepatology (1996) 1.59
Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology (1998) 1.39
Torsade de pointes: the clinical considerations. Int J Cardiol (2004) 1.24
Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation. Liver Int (2003) 1.17
Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol (2006) 1.08
QT interval as a cardiac risk factor in a middle aged population. Heart (1997) 1.06
Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis. J Hepatol (2004) 1.03
New insights into cirrhotic cardiomyopathy. Int J Cardiol (2012) 1.02
Dyssynchronous electrical and mechanical systole in patients with cirrhosis. J Hepatol (2002) 0.95
Potassium currents in atrial and ventricular myocytes from a rat model of cirrhosis. Am J Physiol (1997) 0.95
QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt. J Hepatol (2003) 0.92
The QT interval and cardiac arrhythmias. Annu Rev Med (1987) 0.92
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. J Hepatol (2007) 0.92
QT interval analysis in patients with chronic liver disease: a prospective study. Angiology (2007) 0.91
Cirrhotic cardiomyopathy. Ann Hepatol (2006) 0.88
Autonomic regulation of heart rate and QT interval in nonalcoholic cirrhosis with ascites. Digestion (1997) 0.87
Q-T interval prolongation in liver cirrhosis. Reversibility after orthotopic liver transplantation. Jpn Heart J (1998) 0.86
Cardiac dysfunction in cirrhosis - does adrenal function play a role? A hypothesis. Liver Int (2012) 0.85
Effect of cirrhosis and liver transplantation on the gender difference in QT interval. Am J Cardiol (2005) 0.83
Alterations in corrected QT interval following liver transplant in patients with end-stage liver disease. Clin Cardiol (2010) 0.82
Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia (1996) 0.82
Effects of orthotopic liver transplantation on the corrected QT interval in patients with end-stage liver disease. Dig Dis Sci (2005) 0.82
New age- and sex-specific criteria for QT prolongation based on rate correction formulas that minimize bias at the upper normal limits. Int J Cardiol (2014) 0.81
QT interval correction in patients with cirrhosis. J Cardiovasc Electrophysiol (2007) 0.81
Prolongation of the QTc-interval reflects the severity of autonomic neuropathy in primary biliary cirrhosis and in other non-alcoholic liver diseases. Z Gastroenterol (1993) 0.80
Prolonged QTc interval and its relationship to autonomic cardiovascular reflexes in patients with cirrhosis. J Hepatol (2001) 0.80
Corrected QT interval and QT dispersion in cirrhotic patients before and after liver transplantation. Arch Iran Med (2012) 0.79
Effect of propranolol on the relationship between QT interval and vagal modulation of heart rate variability in cirrhotic patients awaiting liver transplantation. Transplant Proc (2011) 0.79
Serious QT interval prolongation with ranolazine and amiodarone. Int J Cardiol (2013) 0.78
Prevalence of pre-transplant electrocardiographic abnormalities and post-transplant cardiac events in patients with liver cirrhosis. BMC Gastroenterol (2014) 0.78
Novel deletion mutation in the cardiac sodium channel inactivation gate causes long QT syndrome. Int J Cardiol (2012) 0.77
The association of androgens with QT interval and heart rate in US men. Int J Cardiol (2014) 0.77
QTc interval prolongation and hepatic encephalopathy in patients candidates for liver transplantation: A valid inference? Int J Cardiol (2015) 0.77